Literature DB >> 28166548

Nicotine, Carcinogen, and Toxin Exposure in Long-Term E-Cigarette and Nicotine Replacement Therapy Users: A Cross-sectional Study.

Lion Shahab1, Maciej L Goniewicz1, Benjamin C Blount1, Jamie Brown1, Ann McNeill1, K Udeni Alwis1, June Feng1, Lanqing Wang1, Robert West1.   

Abstract

BACKGROUND: Given the rapid increase in the popularity of e-cigarettes and the paucity of associated longitudinal health-related data, the need to assess the potential risks of long-term use is essential.
OBJECTIVE: To compare exposure to nicotine, tobacco-related carcinogens, and toxins among smokers of combustible cigarettes only, former smokers with long-term e-cigarette use only, former smokers with long-term nicotine replacement therapy (NRT) use only, long-term dual users of both combustible cigarettes and e-cigarettes, and long-term users of both combustible cigarettes and NRT.
DESIGN: Cross-sectional study.
SETTING: United Kingdom. PARTICIPANTS: The following 5 groups were purposively recruited: combustible cigarette-only users, former smokers with long-term (≥6 months) e-cigarette-only or NRT-only use, and long-term dual combustible cigarette-e-cigarette or combustible cigarette-NRT users (n = 36 to 37 per group; total n = 181). MEASUREMENTS: Sociodemographic and smoking characteristics were assessed. Participants provided urine and saliva samples and were analyzed for biomarkers of nicotine, tobacco-specific N-nitrosamines (TSNAs), and volatile organic compounds (VOCs).
RESULTS: After confounders were controlled for, no clear between-group differences in salivary or urinary biomarkers of nicotine intake were found. The e-cigarette-only and NRT-only users had significantly lower metabolite levels for TSNAs (including the carcinogenic metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol [NNAL]) and VOCs (including metabolites of the toxins acrolein; acrylamide; acrylonitrile; 1,3-butadiene; and ethylene oxide) than combustible cigarette-only, dual combustible cigarette-e-cigarette, or dual combustible cigarette-NRT users. The e-cigarette-only users had significantly lower NNAL levels than all other groups. Combustible cigarette-only, dual combustible cigarette-NRT, and dual combustible cigarette-e-cigarette users had largely similar levels of TSNA and VOC metabolites. LIMITATION: Cross-sectional design with self-selected sample.
CONCLUSION: Former smokers with long-term e-cigarette-only or NRT-only use may obtain roughly similar levels of nicotine compared with smokers of combustible cigarettes only, but results varied. Long-term NRT-only and e-cigarette-only use, but not dual use of NRTs or e-cigarettes with combustible cigarettes, is associated with substantially reduced levels of measured carcinogens and toxins relative to smoking only combustible cigarettes. PRIMARY FUNDING SOURCE: Cancer Research UK.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28166548      PMCID: PMC5362067          DOI: 10.7326/M16-1107

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  64 in total

1.  Changes in puffing behavior among smokers who switched from tobacco to electronic cigarettes.

Authors:  Yong Hee Lee; Michal Gawron; Maciej Lukasz Goniewicz
Journal:  Addict Behav       Date:  2015-04-16       Impact factor: 3.913

2.  Reinforcing effects of nicotine and non-nicotine components of cigarette smoke.

Authors:  Jed E Rose; Al Salley; Frederique M Behm; James E Bates; Eric C Westman
Journal:  Psychopharmacology (Berl)       Date:  2010-04-01       Impact factor: 4.530

3.  Quantitative analysis of five tobacco-specific N-nitrosamines in urine by liquid chromatography-atmospheric pressure ionization tandem mass spectrometry.

Authors:  Baoyun Xia; Yang Xia; Joshua Wong; Keegan J Nicodemus; Meng Xu; John Lee; Tonya Guillot; James Li
Journal:  Biomed Chromatogr       Date:  2013-10-11       Impact factor: 1.902

4.  Evaluation of toxicant and carcinogen metabolites in the urine of e-cigarette users versus cigarette smokers.

Authors:  Stephen S Hecht; Steven G Carmella; Delshanee Kotandeniya; Makenzie E Pillsbury; Menglan Chen; Benjamin W S Ransom; Rachel Isaksson Vogel; Elizabeth Thompson; Sharon E Murphy; Dorothy K Hatsukami
Journal:  Nicotine Tob Res       Date:  2014-10-21       Impact factor: 4.244

Review 5.  An international literature survey of "IARC Group I carcinogens" reported in mainstream cigarette smoke.

Authors:  C J Smith; S D Livingston; D J Doolittle
Journal:  Food Chem Toxicol       Date:  1997 Oct-Nov       Impact factor: 6.023

6.  Interviews with "vapers": implications for future research with electronic cigarettes.

Authors:  Amy McQueen; Stephanie Tower; Walton Sumner
Journal:  Nicotine Tob Res       Date:  2011-05-12       Impact factor: 4.244

7.  Selected ion monitoring method for determination of nicotine, cotinine and deuterium-labeled analogs: absence of an isotope effect in the clearance of (S)-nicotine-3',3'-d2 in humans.

Authors:  P Jacob; L Yu; M Wilson; N L Benowitz
Journal:  Biol Mass Spectrom       Date:  1991-05

8.  Levels of selected carcinogens and toxicants in vapour from electronic cigarettes.

Authors:  Maciej Lukasz Goniewicz; Jakub Knysak; Michal Gawron; Leon Kosmider; Andrzej Sobczak; Jolanta Kurek; Adam Prokopowicz; Magdalena Jablonska-Czapla; Czeslawa Rosik-Dulewska; Christopher Havel; Peyton Jacob; Neal Benowitz
Journal:  Tob Control       Date:  2013-03-06       Impact factor: 7.552

9.  Urinary biomarkers of smokers' exposure to tobacco smoke constituents in tobacco products assessment: a fit for purpose approach.

Authors:  Evan O Gregg; Emmanuel Minet; Michael McEwan
Journal:  Biomarkers       Date:  2013-07-31       Impact factor: 2.658

10.  Effects of Switching to Electronic Cigarettes with and without Concurrent Smoking on Exposure to Nicotine, Carbon Monoxide, and Acrolein.

Authors:  Hayden McRobbie; Anna Phillips; Maciej L Goniewicz; Katie Myers Smith; Oliver Knight-West; Dunja Przulj; Peter Hajek
Journal:  Cancer Prev Res (Phila)       Date:  2015-09
View more
  160 in total

1.  Tobacco-Specific Nitrosamines (NNAL, NNN, NAT, and NAB) Exposures in the US Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014).

Authors:  Baoyun Xia; Benjamin C Blount; Tonya Guillot; Christina Brosius; Yao Li; Dana M Van Bemmel; Heather L Kimmel; Cindy M Chang; Nicolette Borek; Kathryn C Edwards; Charlie Lawrence; Andrew Hyland; Maciej L Goniewicz; Brittany N Pine; Yang Xia; John T Bernert; B Rey De Castro; John Lee; Justin L Brown; Stephen Arnstein; Diane Choi; Erin L Wade; Dorothy Hatsukami; Gladys Ervies; Angel Cobos; Keegan Nicodemus; Dana Freeman; Stephen S Hecht; Kevin Conway; Lanqing Wang
Journal:  Nicotine Tob Res       Date:  2021-02-16       Impact factor: 4.244

2.  Longitudinal transitions of exclusive and polytobacco electronic nicotine delivery systems (ENDS) use among youth, young adults and adults in the USA: findings from the PATH Study Waves 1-3 (2013-2016).

Authors:  Cassandra A Stanton; Eva Sharma; Kathryn C Edwards; Michael J Halenar; Kristie A Taylor; Karin A Kasza; Hannah Day; Gabriella Anic; Lisa D Gardner; Hoda T Hammad; Maansi Bansal-Travers; Jean Limpert; Nicolette Borek; Heather L Kimmel; Wilson M Compton; Andrew Hyland
Journal:  Tob Control       Date:  2020-05       Impact factor: 7.552

Review 3.  E-cigarette use as a potential cardiovascular disease risk behavior.

Authors:  Krysten W Bold; Suchitra Krishnan-Sarin; Catherine M Stoney
Journal:  Am Psychol       Date:  2018-11

4.  Associations of Cigarettes Smoked Per Day with Biomarkers of Exposure Among U.S. Adult Cigarette Smokers in the Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014).

Authors:  Brian L Rostron; Catherine G Corey; Joanne T Chang; Dana M van Bemmel; Mollie E Miller; Cindy M Chang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-06-25       Impact factor: 4.254

5.  Differences in norms towards the use of nicotine vaping products among adult smokers, former smokers and nicotine vaping product users: cross-sectional findings from the 2016 ITC Four Country Smoking and Vaping Survey.

Authors:  Sarah Aleyan; Katherine East; Ann McNeill; K Michael Cummings; Geoffrey T Fong; Hua-Hie Yong; James F Thrasher; Ron Borland; Sara C Hitchman
Journal:  Addiction       Date:  2019-06-18       Impact factor: 6.526

6.  Indicators of cigarette smoking dependence and relapse in former smokers who vape compared with those who do not: findings from the 2016 International Tobacco Control Four Country Smoking and Vaping Survey.

Authors:  Ann McNeill; Pete Driezen; Sara C Hitchman; K Michael Cummings; Geoffrey T Fong; Ron Borland
Journal:  Addiction       Date:  2019-08-15       Impact factor: 6.526

Review 7.  How close are we to definitively identifying the respiratory health effects of e-cigarettes?

Authors:  Alexsandra Ratajczak; Wojciech Feleszko; Danielle M Smith; Maciej Goniewicz
Journal:  Expert Rev Respir Med       Date:  2018-06-08       Impact factor: 3.772

8.  Disentangling Within- and Between-Person Effects of Shared Risk Factors on E-cigarette and Cigarette Use Trajectories From Late Adolescence to Young Adulthood.

Authors:  Michael S Dunbar; Jordan P Davis; Anthony Rodriguez; Joan S Tucker; Rachana Seelam; Elizabeth J D'Amico
Journal:  Nicotine Tob Res       Date:  2019-09-19       Impact factor: 4.244

9.  Dual Versus Never Use of E-Cigarettes Among American Indians Who Smoke.

Authors:  Dorothy A Rhoades; Ashley L Comiford; Justin D Dvorak; Kai Ding; Leslie M Driskill; Audrea M Hopkins; Paul Spicer; Theodore L Wagener; Mark P Doescher
Journal:  Am J Prev Med       Date:  2019-08-01       Impact factor: 5.043

10.  Characteristics of nicotine vaping products used by participants in the 2016 ITC Four Country Smoking and Vaping Survey.

Authors:  Richard J O'Connor; Brian V Fix; Ann McNeill; Maciej L Goniewicz; Maansi Bansal-Travers; Bryan W Heckman; K Michael Cummings; Sara Hitchman; Ron Borland; David Hammond; David Levy; Shannon Gravely; Geoffrey T Fong
Journal:  Addiction       Date:  2019-04-30       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.